Fresenius SE KGaA Q2 2025 Earnings: Revenue Up 2.2%, Net Income Rises 75%

Fresenius SE KGaA reported Q2 2025 earnings with revenues of €5.58 billion, up 2.2% from Q2 2024. Net income increased by 75% to €332 million, and the profit margin rose to 5.9% from 3.5% in the previous year. Revenue exceeded analyst estimates by 3.7%. The company's shares are up 6.4% from a week ago, and revenue is forecast to grow 4.7% p.a. on average during the next three years.

Fresenius SE KGaA reported its Q2 2025 earnings with revenues of €5,571 million, up 5% from the previous year. The company's net income increased by 8% to €412 million, and the profit margin rose to 11.7% from 12.2% in the previous year. Revenue exceeded analyst estimates by 3.7% [1].

Fresenius Kabi and Fresenius Helios, the company's core businesses, both delivered strong results. Fresenius Kabi reported organic revenue growth of 6% mainly driven by its Growth Vectors and Biopharma segments. Fresenius Helios, on the other hand, reported a 5% organic revenue increase, partially offset by the absence of energy relief funds in Germany [1].

The company's shares are up 6.4% from a week ago, reflecting investor confidence in the company's performance. Fresenius has raised its full-year expectations for revenue growth to between 5% and 7% [1].

References:
[1] https://www.fresenius.com/press-release-q2-2025